CN1628640A - 择时释放渗透泵控释片 - Google Patents
择时释放渗透泵控释片 Download PDFInfo
- Publication number
- CN1628640A CN1628640A CN 200310121359 CN200310121359A CN1628640A CN 1628640 A CN1628640 A CN 1628640A CN 200310121359 CN200310121359 CN 200310121359 CN 200310121359 A CN200310121359 A CN 200310121359A CN 1628640 A CN1628640 A CN 1628640A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- releasing
- selecting
- layer
- semipermeable membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003578 releasing effect Effects 0.000 title claims abstract description 35
- 230000003204 osmotic effect Effects 0.000 title claims abstract description 20
- 239000012528 membrane Substances 0.000 claims abstract description 44
- 239000003814 drug Substances 0.000 claims abstract description 40
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract description 32
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 31
- -1 polyoxyethylene Polymers 0.000 claims abstract description 22
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 18
- 239000000314 lubricant Substances 0.000 claims abstract description 16
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229920002678 cellulose Polymers 0.000 claims abstract description 9
- 239000001913 cellulose Substances 0.000 claims abstract description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 34
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 20
- 229940079593 drug Drugs 0.000 claims description 19
- 230000001737 promoting effect Effects 0.000 claims description 19
- 239000011780 sodium chloride Substances 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 16
- 229920002301 cellulose acetate Polymers 0.000 claims description 13
- 239000011248 coating agent Substances 0.000 claims description 13
- 238000000576 coating method Methods 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 239000003361 porogen Substances 0.000 claims description 12
- 238000005553 drilling Methods 0.000 claims description 10
- 239000001103 potassium chloride Substances 0.000 claims description 10
- 235000011164 potassium chloride Nutrition 0.000 claims description 10
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 7
- 239000013543 active substance Substances 0.000 claims description 6
- 229960000881 verapamil hydrochloride Drugs 0.000 claims description 6
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 5
- 206010020772 Hypertension Diseases 0.000 claims description 5
- DOQPXTMNIUCOSY-UHFFFAOYSA-N [4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]-[2-(3,4-dimethoxyphenyl)ethyl]-methylazanium;chloride Chemical compound [H+].[Cl-].C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 DOQPXTMNIUCOSY-UHFFFAOYSA-N 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 5
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 5
- 206010002383 Angina Pectoris Diseases 0.000 claims description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- 239000004606 Fillers/Extenders Substances 0.000 claims description 4
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 4
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical class [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 4
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 4
- 229940071826 hydroxyethyl cellulose Drugs 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 239000000600 sorbitol Substances 0.000 claims description 4
- 235000010356 sorbitol Nutrition 0.000 claims description 4
- RMMXLENWKUUMAY-UHFFFAOYSA-N telmisartan Chemical compound CCCC1=NC2=C(C)C=C(C=3N(C4=CC=CC=C4N=3)C)C=C2N1CC(C=C1)=CC=C1C1=CC=CC=C1C(O)=O RMMXLENWKUUMAY-UHFFFAOYSA-N 0.000 claims description 4
- 235000010489 acacia gum Nutrition 0.000 claims description 3
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 3
- 208000006673 asthma Diseases 0.000 claims description 3
- 206010012601 diabetes mellitus Diseases 0.000 claims description 3
- 229960004166 diltiazem Drugs 0.000 claims description 3
- PVHUJELLJLJGLN-INIZCTEOSA-N (S)-nitrendipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@@H]1C1=CC=CC([N+]([O-])=O)=C1 PVHUJELLJLJGLN-INIZCTEOSA-N 0.000 claims description 2
- TZNOWAJJWCGILX-BTJKTKAUSA-N (z)-but-2-enedioic acid;3-o-ethyl 5-o-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound OC(=O)\C=C/C(O)=O.CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl TZNOWAJJWCGILX-BTJKTKAUSA-N 0.000 claims description 2
- LLJFMFZYVVLQKT-UHFFFAOYSA-N 1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-2-isoquinolinyl)ethyl]phenyl]sulfonylurea Chemical compound C=1C(OC)=CC=C(C(C2=O)(C)C)C=1C(=O)N2CCC(C=C1)=CC=C1S(=O)(=O)NC(=O)NC1CCCCC1 LLJFMFZYVVLQKT-UHFFFAOYSA-N 0.000 claims description 2
- UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 claims description 2
- 239000004925 Acrylic resin Substances 0.000 claims description 2
- 229920000178 Acrylic resin Polymers 0.000 claims description 2
- 208000006820 Arthralgia Diseases 0.000 claims description 2
- 239000002083 C09CA01 - Losartan Substances 0.000 claims description 2
- 239000004072 C09CA03 - Valsartan Substances 0.000 claims description 2
- 239000002053 C09CA06 - Candesartan Substances 0.000 claims description 2
- 239000005537 C09CA07 - Telmisartan Substances 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 239000001856 Ethyl cellulose Substances 0.000 claims description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
- ZBBHBTPTTSWHBA-UHFFFAOYSA-N Nicardipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)CC=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZBBHBTPTTSWHBA-UHFFFAOYSA-N 0.000 claims description 2
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 claims description 2
- 239000000006 Nitroglycerin Substances 0.000 claims description 2
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 claims description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 claims description 2
- BNPSSFBOAGDEEL-UHFFFAOYSA-N albuterol sulfate Chemical compound OS(O)(=O)=O.CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1.CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 BNPSSFBOAGDEEL-UHFFFAOYSA-N 0.000 claims description 2
- 229960000528 amlodipine Drugs 0.000 claims description 2
- ZPBWCRDSRKPIDG-UHFFFAOYSA-N amlodipine benzenesulfonate Chemical compound OS(=O)(=O)C1=CC=CC=C1.CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl ZPBWCRDSRKPIDG-UHFFFAOYSA-N 0.000 claims description 2
- 229960004005 amlodipine besylate Drugs 0.000 claims description 2
- 229960000932 candesartan Drugs 0.000 claims description 2
- SGZAIDDFHDDFJU-UHFFFAOYSA-N candesartan Chemical compound CCOC1=NC2=CC=CC(C(O)=O)=C2N1CC(C=C1)=CC=C1C1=CC=CC=C1C1=NN=N[N]1 SGZAIDDFHDDFJU-UHFFFAOYSA-N 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 claims description 2
- 229920001249 ethyl cellulose Polymers 0.000 claims description 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
- ZJJXGWJIGJFDTL-UHFFFAOYSA-N glipizide Chemical compound C1=NC(C)=CN=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZJJXGWJIGJFDTL-UHFFFAOYSA-N 0.000 claims description 2
- 229960001381 glipizide Drugs 0.000 claims description 2
- 229960003468 gliquidone Drugs 0.000 claims description 2
- 229960003711 glyceryl trinitrate Drugs 0.000 claims description 2
- YWXYYJSYQOXTPL-SLPGGIOYSA-N isosorbide mononitrate Chemical compound [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-SLPGGIOYSA-N 0.000 claims description 2
- 229960003827 isosorbide mononitrate Drugs 0.000 claims description 2
- 229960004340 lacidipine Drugs 0.000 claims description 2
- GKQPCPXONLDCMU-CCEZHUSRSA-N lacidipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1C1=CC=CC=C1\C=C\C(=O)OC(C)(C)C GKQPCPXONLDCMU-CCEZHUSRSA-N 0.000 claims description 2
- 229960004773 losartan Drugs 0.000 claims description 2
- KJJZZJSZUJXYEA-UHFFFAOYSA-N losartan Chemical compound CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C=2[N]N=NN=2)C=C1 KJJZZJSZUJXYEA-UHFFFAOYSA-N 0.000 claims description 2
- HTMIBDQKFHUPSX-UHFFFAOYSA-N methdilazine Chemical group C1N(C)CCC1CN1C2=CC=CC=C2SC2=CC=CC=C21 HTMIBDQKFHUPSX-UHFFFAOYSA-N 0.000 claims description 2
- VKQFCGNPDRICFG-UHFFFAOYSA-N methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1C1=CC=CC=C1[N+]([O-])=O VKQFCGNPDRICFG-UHFFFAOYSA-N 0.000 claims description 2
- 229960001783 nicardipine Drugs 0.000 claims description 2
- 229960000715 nimodipine Drugs 0.000 claims description 2
- 229960000227 nisoldipine Drugs 0.000 claims description 2
- 229960005425 nitrendipine Drugs 0.000 claims description 2
- 238000012946 outsourcing Methods 0.000 claims description 2
- 235000002639 sodium chloride Nutrition 0.000 claims description 2
- 229960005187 telmisartan Drugs 0.000 claims description 2
- 229960004699 valsartan Drugs 0.000 claims description 2
- SJSNUMAYCRRIOM-QFIPXVFZSA-N valsartan Chemical compound C1=CC(CN(C(=O)CCCC)[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=CC=C1C1=NN=N[N]1 SJSNUMAYCRRIOM-QFIPXVFZSA-N 0.000 claims description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims 1
- KLDXJTOLSGUMSJ-JGWLITMVSA-N Isosorbide Chemical compound O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 KLDXJTOLSGUMSJ-JGWLITMVSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 229960002479 isosorbide Drugs 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 27
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical group [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- 238000003756 stirring Methods 0.000 description 9
- 235000019359 magnesium stearate Nutrition 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000002156 mixing Methods 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 6
- 230000036571 hydration Effects 0.000 description 6
- 238000006703 hydration reaction Methods 0.000 description 6
- 230000035699 permeability Effects 0.000 description 6
- 238000013270 controlled release Methods 0.000 description 5
- 229960004756 ethanol Drugs 0.000 description 5
- 238000013461 design Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 230000033764 rhythmic process Effects 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KSZVHVUMUSIKTC-UHFFFAOYSA-N acetic acid;propan-2-one Chemical compound CC(C)=O.CC(O)=O KSZVHVUMUSIKTC-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000007779 soft material Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- FEDJGPQLLNQAIY-UHFFFAOYSA-N 2-[(6-oxo-1h-pyridazin-3-yl)oxy]acetic acid Chemical compound OC(=O)COC=1C=CC(=O)NN=1 FEDJGPQLLNQAIY-UHFFFAOYSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229960005316 diltiazem hydrochloride Drugs 0.000 description 2
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 2
- 229960001597 nifedipine Drugs 0.000 description 2
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000027288 circadian rhythm Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- PTVWPYVOOKLBCG-ZDUSSCGKSA-N levodropropizine Chemical compound C1CN(C[C@H](O)CO)CCN1C1=CC=CC=C1 PTVWPYVOOKLBCG-ZDUSSCGKSA-N 0.000 description 1
- 229960002265 levodropropizine Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200310121359A CN100574748C (zh) | 2003-12-15 | 2003-12-15 | 择时释放渗透泵控释片 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200310121359A CN100574748C (zh) | 2003-12-15 | 2003-12-15 | 择时释放渗透泵控释片 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1628640A true CN1628640A (zh) | 2005-06-22 |
CN100574748C CN100574748C (zh) | 2009-12-30 |
Family
ID=34844155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200310121359A Expired - Lifetime CN100574748C (zh) | 2003-12-15 | 2003-12-15 | 择时释放渗透泵控释片 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100574748C (zh) |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100457103C (zh) * | 2006-06-28 | 2009-02-04 | 广州贝氏药业有限公司 | 非洛地平双层渗透泵控释药物组合物 |
CN100464740C (zh) * | 2006-06-30 | 2009-03-04 | 清华大学 | 羟基喜树碱固体分散物的渗透泵控释片及其制备方法 |
CN101152228B (zh) * | 2006-09-28 | 2010-08-18 | 成都中医药大学 | 人参总皂苷微孔渗透泵片及其制备方法 |
CN101940578A (zh) * | 2010-08-25 | 2011-01-12 | 山东新华制药股份有限公司 | 一种用于治疗2型糖尿病的药物组合物及其制备方法 |
WO2011063732A1 (zh) * | 2009-11-26 | 2011-06-03 | 中国科学院上海药物研究所 | 一种帕利哌酮双层渗透泵控释片及其制备方法 |
WO2011072474A1 (zh) * | 2009-12-15 | 2011-06-23 | 北京协和药厂 | 双环醇双层渗透泵控释片剂及其制备方法 |
CN102151252A (zh) * | 2010-02-11 | 2011-08-17 | 北京天衡药物研究院南阳天衡制药厂 | 格列吡嗪渗透泵型控释片 |
CN102151253A (zh) * | 2010-02-11 | 2011-08-17 | 北京天衡药物研究院 | 硝苯地平渗透泵型控释片 |
CN102166202A (zh) * | 2011-04-21 | 2011-08-31 | 沈阳药科大学 | 格列喹酮双层渗透泵控释片及其制备方法 |
CN102178677A (zh) * | 2011-03-02 | 2011-09-14 | 合肥华方医药科技有限公司 | 硝苯地平双层渗透泵药物组合物及其制备工艺 |
CN101732275B (zh) * | 2009-11-26 | 2011-12-21 | 中国科学院上海药物研究所 | 一种单硝酸异山梨酯双层渗透泵控释片及其制备方法 |
CN102423305A (zh) * | 2011-12-23 | 2012-04-25 | 中国药科大学 | 单硝酸异山梨酯微孔渗透泵片及其制备方法 |
CN102485219A (zh) * | 2010-12-03 | 2012-06-06 | 沈阳药科大学 | 盐酸地尔硫卓延迟释放双层渗透泵控释片及其制备方法 |
CN101732276B (zh) * | 2009-12-26 | 2012-09-12 | 鲁南制药集团股份有限公司 | 一种单硝酸异山梨酯的片剂 |
CN102670540A (zh) * | 2011-03-14 | 2012-09-19 | 北京天衡药物研究院南阳天衡制药厂 | 盐酸维拉帕米渗透泵型控释片 |
CN102670559A (zh) * | 2011-03-14 | 2012-09-19 | 北京天衡药物研究院南阳天衡制药厂 | 硫酸沙丁胺醇渗透泵控释片 |
CN102670560A (zh) * | 2011-03-17 | 2012-09-19 | 北京天衡药物研究院 | 氯沙坦钾渗透泵控释片 |
CN101703488B (zh) * | 2008-12-16 | 2013-02-20 | 北京科信必成医药科技发展有限公司 | 具有润滑层结构的双层渗透泵控释片及其制备方法 |
CN103371983A (zh) * | 2012-04-28 | 2013-10-30 | 合肥华方医药科技有限公司 | 基于溶蚀渗透机理的硫酸沙丁胺醇控释制剂 |
CN103565774A (zh) * | 2012-08-10 | 2014-02-12 | 石药集团中奇制药技术(石家庄)有限公司 | 一种格列吡嗪控释组合物及其制备方法 |
CN103565772A (zh) * | 2012-08-10 | 2014-02-12 | 石药集团中奇制药技术(石家庄)有限公司 | 一种格列吡嗪控释组合物及其制备方法 |
CN103565769A (zh) * | 2012-07-18 | 2014-02-12 | 石药集团中奇制药技术(石家庄)有限公司 | 一种硝苯地平控释组合物及其制备方法 |
CN103690514A (zh) * | 2013-12-25 | 2014-04-02 | 润泽制药(苏州)有限公司 | 氨氯地平择时控释胶囊及其制备方法 |
CN105581993A (zh) * | 2016-03-11 | 2016-05-18 | 常州欧法玛制药技术有限公司 | 一种阿司匹林渗透泵控释片及其制备方法 |
WO2023015847A1 (zh) * | 2021-08-09 | 2023-02-16 | 北京五和博澳药业股份有限公司 | 一种难溶性药物渗透泵控释片剂及其制备方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108888604A (zh) * | 2018-07-27 | 2018-11-27 | 深圳市泛谷药业股份有限公司 | 一种米那普仑择时延迟控释渗透泵控释片及其制备方法 |
-
2003
- 2003-12-15 CN CN200310121359A patent/CN100574748C/zh not_active Expired - Lifetime
Cited By (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100457103C (zh) * | 2006-06-28 | 2009-02-04 | 广州贝氏药业有限公司 | 非洛地平双层渗透泵控释药物组合物 |
CN100464740C (zh) * | 2006-06-30 | 2009-03-04 | 清华大学 | 羟基喜树碱固体分散物的渗透泵控释片及其制备方法 |
CN101152228B (zh) * | 2006-09-28 | 2010-08-18 | 成都中医药大学 | 人参总皂苷微孔渗透泵片及其制备方法 |
CN101703488B (zh) * | 2008-12-16 | 2013-02-20 | 北京科信必成医药科技发展有限公司 | 具有润滑层结构的双层渗透泵控释片及其制备方法 |
GB2488731B (en) * | 2009-11-26 | 2017-11-22 | Shanghai Inst Materia Medica Cas | Paliperidone double-layered osmotic pump controlled release tablet and preparation method thereof |
WO2011063732A1 (zh) * | 2009-11-26 | 2011-06-03 | 中国科学院上海药物研究所 | 一种帕利哌酮双层渗透泵控释片及其制备方法 |
CN101732275B (zh) * | 2009-11-26 | 2011-12-21 | 中国科学院上海药物研究所 | 一种单硝酸异山梨酯双层渗透泵控释片及其制备方法 |
US8920835B2 (en) | 2009-11-26 | 2014-12-30 | Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | Paliperidone double-layered osmotic pump controlled release tablet and preparation method thereof |
GB2488731A (en) * | 2009-11-26 | 2012-09-05 | Shanghai Inst Materia Medica | Paliperidone double-layered osmotic pump controlled release tablet and preparation method thereof |
WO2011072474A1 (zh) * | 2009-12-15 | 2011-06-23 | 北京协和药厂 | 双环醇双层渗透泵控释片剂及其制备方法 |
CN101732276B (zh) * | 2009-12-26 | 2012-09-12 | 鲁南制药集团股份有限公司 | 一种单硝酸异山梨酯的片剂 |
CN102151252A (zh) * | 2010-02-11 | 2011-08-17 | 北京天衡药物研究院南阳天衡制药厂 | 格列吡嗪渗透泵型控释片 |
CN102151253A (zh) * | 2010-02-11 | 2011-08-17 | 北京天衡药物研究院 | 硝苯地平渗透泵型控释片 |
CN102151252B (zh) * | 2010-02-11 | 2014-06-11 | 北京天衡药物研究院南阳天衡制药厂 | 格列吡嗪渗透泵型控释片 |
CN102151253B (zh) * | 2010-02-11 | 2013-10-16 | 北京天衡药物研究院 | 硝苯地平渗透泵型控释片 |
CN101940578A (zh) * | 2010-08-25 | 2011-01-12 | 山东新华制药股份有限公司 | 一种用于治疗2型糖尿病的药物组合物及其制备方法 |
CN102485219A (zh) * | 2010-12-03 | 2012-06-06 | 沈阳药科大学 | 盐酸地尔硫卓延迟释放双层渗透泵控释片及其制备方法 |
CN102178677A (zh) * | 2011-03-02 | 2011-09-14 | 合肥华方医药科技有限公司 | 硝苯地平双层渗透泵药物组合物及其制备工艺 |
CN102178677B (zh) * | 2011-03-02 | 2015-01-21 | 合肥华方医药科技有限公司 | 硝苯地平双层渗透泵药物组合物及其制备工艺 |
CN102670540B (zh) * | 2011-03-14 | 2016-03-09 | 北京天衡药物研究院南阳天衡制药厂 | 盐酸维拉帕米渗透泵型控释片 |
CN102670559A (zh) * | 2011-03-14 | 2012-09-19 | 北京天衡药物研究院南阳天衡制药厂 | 硫酸沙丁胺醇渗透泵控释片 |
CN102670540A (zh) * | 2011-03-14 | 2012-09-19 | 北京天衡药物研究院南阳天衡制药厂 | 盐酸维拉帕米渗透泵型控释片 |
CN102670560A (zh) * | 2011-03-17 | 2012-09-19 | 北京天衡药物研究院 | 氯沙坦钾渗透泵控释片 |
CN102166202A (zh) * | 2011-04-21 | 2011-08-31 | 沈阳药科大学 | 格列喹酮双层渗透泵控释片及其制备方法 |
CN102423305A (zh) * | 2011-12-23 | 2012-04-25 | 中国药科大学 | 单硝酸异山梨酯微孔渗透泵片及其制备方法 |
CN103371983A (zh) * | 2012-04-28 | 2013-10-30 | 合肥华方医药科技有限公司 | 基于溶蚀渗透机理的硫酸沙丁胺醇控释制剂 |
CN103565769A (zh) * | 2012-07-18 | 2014-02-12 | 石药集团中奇制药技术(石家庄)有限公司 | 一种硝苯地平控释组合物及其制备方法 |
CN103565769B (zh) * | 2012-07-18 | 2017-08-01 | 石药集团中奇制药技术(石家庄)有限公司 | 一种硝苯地平控释组合物及其制备方法 |
CN103565772A (zh) * | 2012-08-10 | 2014-02-12 | 石药集团中奇制药技术(石家庄)有限公司 | 一种格列吡嗪控释组合物及其制备方法 |
CN103565774B (zh) * | 2012-08-10 | 2017-11-03 | 石药集团中奇制药技术(石家庄)有限公司 | 一种格列吡嗪控释组合物及其制备方法 |
CN103565774A (zh) * | 2012-08-10 | 2014-02-12 | 石药集团中奇制药技术(石家庄)有限公司 | 一种格列吡嗪控释组合物及其制备方法 |
CN103690514B (zh) * | 2013-12-25 | 2015-06-10 | 润泽制药(苏州)有限公司 | 氨氯地平择时控释胶囊及其制备方法 |
CN103690514A (zh) * | 2013-12-25 | 2014-04-02 | 润泽制药(苏州)有限公司 | 氨氯地平择时控释胶囊及其制备方法 |
CN105581993A (zh) * | 2016-03-11 | 2016-05-18 | 常州欧法玛制药技术有限公司 | 一种阿司匹林渗透泵控释片及其制备方法 |
CN105581993B (zh) * | 2016-03-11 | 2018-06-29 | 常州欧法玛制药技术有限公司 | 一种阿司匹林渗透泵控释片及其制备方法 |
WO2023015847A1 (zh) * | 2021-08-09 | 2023-02-16 | 北京五和博澳药业股份有限公司 | 一种难溶性药物渗透泵控释片剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100574748C (zh) | 2009-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1628640A (zh) | 择时释放渗透泵控释片 | |
CN1090018C (zh) | 缓释制剂 | |
CN1213738C (zh) | 对活性成份起缓释作用的高机械稳定性的固体口服剂型 | |
CN1081916C (zh) | 一种控释药物悬浮液的释放装置 | |
CN100563638C (zh) | 硝苯地平控释片及其制备方法 | |
CN1202820A (zh) | 胰岛血糖素样促胰岛素肽的经颊释放 | |
CN102258492B (zh) | 溴新斯的明缓释片剂及其制备方法 | |
WO2011131370A1 (en) | Melt-granulated fingolimod | |
CN100376230C (zh) | 择时缓释微丸及其制剂 | |
CN1741819A (zh) | 用于药物口服给药的缓释组合物 | |
CN1903183A (zh) | 替比夫定分散片及其制备方法 | |
CN110251473B (zh) | 羟哌吡酮口服缓释制剂 | |
CN1679536A (zh) | 单硝酸异山梨酯缓释片 | |
CN101084904B (zh) | 头孢克肟缓释双层片 | |
CN102198107B (zh) | 拉西地平分散片及其制备方法 | |
CN1270700C (zh) | 难溶性药物的单层芯渗透泵片制备方法 | |
CN101172101A (zh) | 格列吡嗪控释片及其制备方法 | |
CN1850057A (zh) | 一种难溶性药物单片芯单室渗透泵控释制剂的制备方法及其产品 | |
CN1191831C (zh) | 复方阿替洛尔硝苯地平缓释制剂 | |
CN101732269A (zh) | 一种含有单硝酸异山梨酯的分散片 | |
CN101040850A (zh) | 秋水仙碱缓释微丸及制备方法 | |
CN1187054C (zh) | 含中药环维黄杨星d的渗透泵控释制剂及其制备方法 | |
CN1589782A (zh) | 盐酸二甲双胍缓释颗粒及制备方法 | |
CN1557330A (zh) | 克林霉素缓释制剂 | |
CN1557309A (zh) | 氨氯地平分散片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20090206 Address after: Room 1410, Beijing satellite building, No. 63, Zhichun Road, Beijing, Haidian District, China: 100080 Applicant after: COSCI MED-TECH Co.,Ltd. Address before: 416, pharmacy research office, research building, Heilongjiang University Of Chinese Medicine, Heilongjiang, Harbin Province, China: 150040 Applicant before: HARBIN SHENLONG CHINESE TRADIT |
|
ASS | Succession or assignment of patent right |
Owner name: KEXIN BICHENG MEDICINE SCIENCE AND TECHNOLOGY DEVE Free format text: FORMER OWNER: HARBIN CITY SHENLONG CHINESE DRUG RESEARCH INSTITUTE Effective date: 20090206 |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 100083 Haidian District, Xueyuan Road, No. 30, A building, room No. 15, room, room 15 Patentee after: COSCI MED-TECH Co.,Ltd. Address before: 100080, Haidian District satellite building, No. 63, Zhichun Road, Beijing, room 1410, Beijing Patentee before: COSCI MED-TECH Co.,Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20050622 Assignee: ZIBO WANJIE PHARMACY CO.,LTD. Assignor: COSCI MED-TECH Co.,Ltd. Contract record no.: 2013990000165 Denomination of invention: Releasing control piece of time-selecting releasing osmotic pump Granted publication date: 20091230 License type: Common License Record date: 20130424 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230428 Address after: 8639, Floor 6, Building 3, No. 3, Yongchang North Road, Daxing District, Beijing, 100176 Patentee after: Beijing Kexin Jurun Pharmaceutical Technology Co.,Ltd. Address before: 100083 room 15, 15 / F, block a, Tiangong building, 30 Xueyuan Road, Haidian District, Beijing Patentee before: COSCI MED-TECH Co.,Ltd. |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20091230 |